Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.780
-0.070 (-3.78%)
Oct 9, 2026, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 207.94 million as of October 9, 2026. It is the 22,928th most valuable company in the world and the 597th biggest in Canada. Its market cap has increased by 65.57% in one year.
Market Cap
207.94M
Enterprise Value
181.97M
Revenue
n/a
Global Rank
Country Rank
#597 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 207.94M, an increase of 120.48%. That is a compound annual growth rate of 10.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 207.94M | 59.51% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 348.70M |
| Cipher Pharmaceuticals | 347.17M |
| Auxly Cannabis Group | 339.64M |
| TerrAscend | 225.70M |
| Cannara Biotech | 209.28M |
| Organigram Global | 196.00M |
| BioSyent | 191.12M |
| Medexus Pharmaceuticals | 153.04M |